Tu2018 - Novel Formulation of CT-P13 (Infliximab Biosimilar) for Subcutaneous Administration: Initial Results from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease

2018 ◽  
Vol 154 (6) ◽  
pp. S-1371 ◽  
Author(s):  
Stefan Schreiber ◽  
Byung Ik Jang ◽  
Vladimir Borzan ◽  
Adi Lahat ◽  
Aldis Pukitis ◽  
...  
2003 ◽  
Vol 124 (4) ◽  
pp. 917-924 ◽  
Author(s):  
Richard J. Farrell ◽  
Mazen Alsahli ◽  
Yoon-Tae Jeen ◽  
Kenneth R. Falchuk ◽  
Mark A. Peppercorn ◽  
...  

1998 ◽  
Vol 115 (1) ◽  
pp. 36-41 ◽  
Author(s):  
Richard J. Robinson ◽  
Tara Krzywicki ◽  
Len Almond ◽  
Farook Al–Azzawi ◽  
Keith Abrams ◽  
...  

2020 ◽  
Vol 158 (6) ◽  
pp. S-1199-S-1200
Author(s):  
Samuel Sassine ◽  
Sonia Alexandra Tchogna ◽  
Colette Deslandres ◽  
Geneviève Mailhot ◽  
Nathalie Alos ◽  
...  

2008 ◽  
Vol 134 (4) ◽  
pp. A-361 ◽  
Author(s):  
Karen Madsen ◽  
Jody L. Backer ◽  
Des Leddin ◽  
Levinus A. Dieleman ◽  
Alain Bitton ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document